» Authors » D E Brenneman

D E Brenneman

Explore the profile of D E Brenneman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 126
Citations 2402
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinhasov A, Ilyin S, Crooke J, Amato F, Vaidya A, Rosenthal D, et al.
Genes Brain Behav . 2005 Jan; 4(1):60-4. PMID: 15660669
Synucleins are small proteins regulating the filamentous network that in turn influences the release of dopamine and glutamate neurotransmitters involved in mood and motivation processes. We have studied the pattern...
2.
Gozes I, Brenneman D, Geppetti P, Kastin A, Mains R, Moody T, et al.
Trends Neurosci . 2001 Nov; 24(12):687-90. PMID: 11718856
Neuropeptides 2001, 2nd Joint Meeting of the European Neuropeptide Club and the American Summer Neuropeptide Conference (11th Annual Meeting). 6-11 May 2001 with Satellite Symposium, Israeli-French Symposium, Israel Ministry of...
3.
Gelber E, Granoth R, Fridkin M, Dreznik Z, Brenneman D, Moody T, et al.
Cancer . 2001 Oct; 92(8):2172-80. PMID: 11596035
Background: Vasoactive intestinal peptide (VIP) is one of several small neuropeptides that affect cancer growth. A lipophilic VIP analog, stearyl-Nle(17)-neuroten-sin(6-11)VIP(7-28) (SNH) that inhibited lung carcinoma growth has been described previously....
4.
Porter A, Auth J, Prince M, Ghidini A, Brenneman D, Spong C
Am J Obstet Gynecol . 2001 Aug; 185(2):459-62. PMID: 11518909
Objective: Many studies use stored amniotic fluid samples to assay cytokines and other proteins for outcome-based research; however, there is little information on the optimal methods of storage. The objective...
5.
Servoss S, Lee S, Gibney G, Gozes I, Brenneman D, Hill J
Endocrinology . 2001 Jul; 142(8):3348-53. PMID: 11459777
IGF-I and the IGF-I receptor are necessary for normal embryonic growth. VIP is an important regulator of early postimplantation growth and acts indirectly through the release of other factors, including...
6.
Ashur-Fabian O, Giladi E, Furman S, Steingart R, Wollman Y, Fridkin M, et al.
Neurosci Lett . 2001 Jul; 307(3):167-70. PMID: 11438390
Nanomolar concentrations of vasoactive intestinal peptide (VIP), picomolar concentrations of stearyl-norleucine17-VIP (SNV) and femtomolar concentrations of NAPVSIPQ (NAP), an 8-amino-acid peptide derived from the VIP-responsive activity-dependent neuroprotective protein, provide broad...
7.
Sigalov E, Fridkin M, Brenneman D, Gozes I
J Mol Neurosci . 2001 Apr; 15(3):147-54. PMID: 11303779
To evaluate the protective properties of peptides related functionally and/or structurally to vasoactive intestinal peptide (VIP), PC12 cultures were treated with iodoacetate as a model for neuronal ischemic/hypoxic injury. Brain...
8.
Steingart R, Solomon B, Brenneman D, Fridkin M, Gozes I
J Mol Neurosci . 2001 Apr; 15(3):137-45. PMID: 11303778
Oxidative stress is a common associative mechanism that is part of the pathogenesis of many neurodegenerative diseases. Vasoactive intestinal peptide (VIP) is a principal neuropeptide associated with normal development and...
9.
Spong C, Abebe D, Gozes I, Brenneman D, Hill J
J Pharmacol Exp Ther . 2001 Apr; 297(2):774-9. PMID: 11303069
Two peptides [NAPVSIPQ (NAP) and SALLRSIPA (ADNF-9)], that are associated with novel glial proteins regulated by vasoactive intestinal peptide, are shown now to provide protective intervention in a model of...
10.
Gozes I, Zamostiano R, Pinhasov A, Bassan M, Giladi E, Steingart R, et al.
Ann N Y Acad Sci . 2001 Feb; 921:115-8. PMID: 11193814
Activity dependent neuroprotective protein (ADNP, 828 amino acids, pI 5.99) is a glial-derived protein that contains a femtomolar active neuroprotective peptide, NAPVSIPQ (NAP). VIP induces a two- to threefold increase...